Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 745.22M P/E 1,188.00 EPS this Y 87.00% Ern Qtrly Grth -
Income -144.16M Forward P/E 79.20 EPS next Y 79.30% 50D Avg Chg -18.00%
Sales 142.36M PEG -2.57 EPS past 5Y - 200D Avg Chg -25.00%
Dividend N/A Price/Book 3.93 EPS next 5Y 15.00% 52W High Chg -44.00%
Recommedations 2.00 Quick Ratio 1.01 Shares Outstanding 63.80M 52W Low Chg 5.00%
Insider Own 1.11% ROA -3.05% Shares Float 50.95M Beta 1.38
Inst Own 104.12% ROE -115.84% Shares Shorted/Prior 12.95M/13.93M Price 11.88
Gross Margin 6.27% Profit Margin -101.27% Avg. Volume 579,688 Target Price 13.50
Oper. Margin -6.11% Earnings Date Dec 5 Volume 520,273 Change -0.25%
About Avid Bioservices, Inc.

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.

Avid Bioservices, Inc. News
09/12/24 Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
09/10/24 Avid Bioservices First Quarter 2025 Earnings: Misses Expectations
09/10/24 Q1 2025 Avid Bioservices Inc Earnings Call
09/09/24 Avid Bioservices: Fiscal Q1 Earnings Snapshot
09/09/24 Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024
09/04/24 Avid Bioservices, Inc. (CDMO): This Small-Cap Healthcare Stock Is A Good Buy Right Now
09/03/24 Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
07/26/24 Does Avid Bioservices (CDMO) have Hidden Potential Despite Current Weakness?
07/02/24 Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
07/01/24 Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
06/12/24 Those who invested in Avid Bioservices (NASDAQ:CDMO) five years ago are up 104%
06/11/24 Halozyme Therapeutics, Inc. (NASDAQ:HALO) Downgraded by Piper Sandler
05/23/24 Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
05/07/24 Avid Bioservices to Participate at Upcoming Investor Conferences
05/03/24 How Novo-Catalent Deal Affects Halozyme (HALO)?
04/30/24 Q3 2024 Avid Bioservices Inc Earnings Call
04/30/24 Avid Bioservices Inc (CDMO) Q3 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
04/24/24 Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
03/20/24 Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
03/10/24 Avid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial Results
CDMO Chatroom

User Image ForUS2Retire Posted - 3 days ago

"Breakout trade WATCH for possible breakout above 11.7 Target: 13.18, 17.8% Stop: 10.63 Loss: 5% P/L ratio: 3.6 : 1 - Excellent" *************************************************** At Least According To: https://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=CDMO Glta $CDMO Bulls, Watchers, & StockHOLDers!

User Image Flexed1ga Posted - 5 days ago

$CDMO new holder

User Image anachartanalyst Posted - 5 days ago

https://anachart.com/market-update/september-11th-2024/ $ASO $CDMO $AAPL

User Image Flexed1ga Posted - 5 days ago

$CDMO new here

User Image 30DeltaSpy Posted - 6 days ago

$CDMO 🐂

User Image IN0V8 Posted - 6 days ago

$CDMO RBC raises target price to $12 from $8

User Image kingofmaryland21 Posted - 6 days ago

$CDMO called it 7 months ago….

User Image CDMO Posted - 6 days ago

$CDMO back over 10, gooooood

User Image ForUS2Retire Posted - 6 days ago

$CDMO UpGAP Closed! Feel Free To BreakOut. Glta Bulls, Watchers, & StockHOLDers!

User Image ForUS2Retire Posted - 1 week ago

FYI, The $CDMO CC Recording Is Now Available. Link: https://edge.media-server.com/mmc/p/krrwjyyg/ Glta

User Image ForUS2Retire Posted - 1 week ago

I Logged In To CC And At $4:30 I Got Disconnected. I Must Have Signed In A Dozen More Times. Only Heard A Few Sentences, But Mostly Silence. A Box Kept Appearing Stating "Dial In Instructions", But Offered No Instructions! Aaarrrggghhh!!! I Guess I Wait For The Recording. Glta $CDMO Investors.

User Image BozoJoeClownShow Posted - 1 week ago

$CDMO Logged into the conference call at 4:15. Heard 15 minutes of music then dead silence. Tried logging in again not a damn thing. While growing backlog is fantastic, how about we actually put some shit out the front door and make some money? Just a thought .

User Image DonCorleone77 Posted - 1 week ago

$CDMO Avid Bioservices backs FY25 revenue view160M-$168M, consensus $162.83M The company is reiterating revenue guidance for fiscal 2025 of $160 million to $168 million.

User Image DonCorleone77 Posted - 1 week ago

$CDMO Avid Bioservices reports Q1 EPS (9c) , consensus (5c) Reports Q1 revenue $40.2M, consensus $40.76M....Signed $66M in Net New Business, Resulting in Backlog of $219 M --"Our first quarter continued the strong momentum we have seen since the completion of our expansion program. We are encouraged by the strong revenues and new business signings, which continue to build our backlog and improve margins," stated Nick Green, president and CEO of Avid Bioservices. "In addition to the strong overall bookings during the quarter, it was encouraging to see the composition of signings, which included a significant number of new customers, a number of early-phase programs, and multiple late-stage programs, including two PPQ campaigns, one of which is a Phase 3 program advancing toward commercialization, and the other is a commercial product. During the quarter, we continued to record strong revenues from process development as we onboarded new business. "The investments of the last few years in infrastructure, facilities, and capacity, and the expansion of our capabilities continue to attract new business and a wider range of opportunities. Our new infrastructure and organization are now better equipped to support the needs of large pharma with the same excellence and agility that we provide smaller biotech companies. We look forward to the continued diversification of our customer base and our project pipeline with key programs from early stage to commercialization. "Looking ahead, our story remains unchanged with our primary focus on filling our remaining capacity. As we continue to sign new business, execute on our backlog and leverage our sterling reputation in the industry, we expect revenues and capacity utilization to increase, generating higher margins, and positioning Avid to achieve strong growth going forward."

User Image CDMO Posted - 1 week ago

$CDMO results are okay, no major suprises i would say

User Image epsguid Posted - 1 week ago

$CDMO reported a loss of $0.07, consensus was ($0.08) via @eWhispers #epsbeat http://eps.sh/d/cdmo

User Image Stock_Titan Posted - 1 week ago

$CDMO $CDMOP Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 https://www.stocktitan.net/news/CDMO/avid-bioservices-reports-financial-results-for-first-quarter-ended-sa731h2eorus.html

User Image ForUS2Retire Posted - 1 week ago

$CDMO CC Link: https://edge.media-server.com/mmc/p/krrwjyyg Glta Investors!

User Image GambitMentality Posted - 1 week ago

With $CDMO reporting earnings today AMC, here is where the money is flowing by Premium in the last 5 minutes of trading with #OptionsTrading

User Image ForUS2Retire Posted - 1 week ago

$CDMO Has Bullishly Low Put/Call Ratio=0.104 Glta Bulls, Watchers, & StockHOLDers!

User Image ForUS2Retire Posted - 1 week ago

TOS Now Shows Potential MarketMakerMove=+/-$3.505 Glta $CDMO StockHOLDers!

User Image ForUS2Retire Posted - 1 week ago

ThinkOrSwim Currently Shows Potential MarketMakerMove Of +/-$2.50, & My Guess Is PPS Will Be Going up, Up, UP, ^U^P^,... Glta $CDMO Bulls, Watchers, & StockHOLDers! Earnings Report After Close...

User Image GambitMentality Posted - 1 week ago

Here are some street estimates on companies reporting earnings in the #StockMarket this week. THESE ARE NOT SIGNALS! These are just expectations with ZERO guidance. Here's info on $CDMO

User Image CDMO Posted - 1 week ago

$CDMO from 12 to 9 in a few days :(

User Image Stock_Titan Posted - 1 week ago

$CDMO $CDMOP Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024 https://www.stocktitan.net/news/CDMO/avid-bioservices-to-report-financial-results-for-first-quarter-of-r1sa7g2eupb4.html

User Image ForUS2Retire Posted - 08/28/24

Any Stock Legal Eagles Read This Board? If So, Have You Read The Recent Avid "FORM ARS" That Was Released Today? If You Read It, Please Post Your Opinions So Everyone Can Remain Informed! Thanks In Advance ;- ) It Is Only Available As A PDF Download: Link: https://ir.avidbio.com/sec-filings/sec-filing/ars/0001683168-24-006083 Glta $CDMO Bulls, Watchers, & StockHOLDers!

User Image insidemoney Posted - 08/27/24

$CDMO Avid Bioservices 14-Day RSI: 56.3 % from 52-Week Low: +160.0% % from 52-Week High: -15.6% Open Interest: 4,602 % Change: 0% Put/Call Ratio: 1.23 % Change: -0.2%

User Image CDMO Posted - 08/26/24

$CDMO i liked 11 better!

User Image BozoJoeClownShow Posted - 08/22/24

$CDMO Ouch

User Image ForUS2Retire Posted - 08/20/24

"Breakout trade: WATCH for possible breakout above 11.68 Target: 12.98, 14.2% Stop: 10.85 Loss: 4.6% P/L ratio: 3.1 : 1 - Excellent" ******************************** At Least According To: https://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=CDMO Glta $CDMO Bulls, Watchers, & StockHOLDers!

Analyst Ratings
RBC Capital Outperform Sep 10, 24
Stephens & Co. Overweight Sep 10, 24
William Blair Market Perform Sep 10, 24
RBC Capital Outperform Jul 3, 24
RBC Capital Outperform Apr 30, 24
Stephens & Co. Overweight Mar 11, 24
RBC Capital Outperform Mar 7, 24
RBC Capital Outperform Dec 8, 23
Craig-Hallum Buy Dec 8, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Jan 11 Sell 6.77 274 1,855 19,829 01/12/24
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Jan 09 Sell 6.17 1,346 8,305 63,269 01/11/24
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jan 09 Sell 6.17 1,171 7,225 5,208 01/11/24
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Jan 09 Sell 6.17 1,060 6,540 19,434 01/11/24
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Jan 09 Sell 6.17 2,408 14,857 79,305 01/11/24
Hancock Richard B Director Director Dec 13 Buy 5.2067 38,803 202,036 117,563 01/10/24
Hancock Richard B Director Director Dec 14 Buy 5.86 23,000 134,780 78,760 12/18/23
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Oct 11 Sell 9.19 255 2,343 17,961 10/13/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Oct 09 Sell 9.2 1,141 10,497 60,515 10/11/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Oct 09 Sell 9.2 1,006 9,255 4,177 10/11/23
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Oct 09 Sell 9.2 970 8,924 17,546 10/11/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Oct 09 Sell 9.2 2,040 18,768 75,081 10/11/23
Carleone Joseph Director Director Sep 21 Buy 9.5348 20,000 190,696 93,956 09/22/23
Green Nicholas Stewart President & CEO President & CEO Jul 30 Sell 12.99 19,519 253,552 145,844 08/01/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jul 13 Sell 13.40 2,734 36,636 4,035 07/14/23
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Jul 11 Sell 13.61 252 3,430 15,984 07/13/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Jul 10 Sell 13.86 5,015 69,508 58,449 07/12/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jul 10 Sell 13.86 1,542 21,372 6,769 07/12/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Jul 10 Sell 13.86 3,763 52,155 71,380 07/12/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Jul 09 Sell 13.77 687 9,460 49,173 07/11/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jul 09 Sell 13.77 564 7,766 6,602 07/11/23
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Jul 09 Sell 13.77 477 6,568 15,567 07/11/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Jul 09 Sell 13.77 1,269 17,474 64,420 07/11/23
Green Nicholas Stewart President & CEO President & CEO Jul 09 Sell 13.77 7,530 103,688 127,863 07/11/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Jun 28 Sell 13.1 3,657 47,907 46,975 06/30/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jun 28 Sell 12.7 2,758 35,027 17,163 06/30/23
Kwietniak Matthew R. Chief Commerical Off.. Chief Commerical Officer Jun 28 Sell 12.7 3,947 50,127 14,067 06/30/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Jun 28 Sell 12.7 6,884 87,427 61,141 06/30/23
Green Nicholas Stewart President & CEO President & CEO Jun 28 Sell 12.7 40,856 518,871 120,067 06/30/23
Hancock Richard B Director Director Jun 06 Sell 16.18 5,000 80,900 39,134 06/08/23
Hancock Richard B Director Director Jun 06 Option 4.53 12 54 39,146 06/08/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel May 01 Sell 17.91 25,000 447,750 40,119 05/02/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel May 01 Option 9.87 25,000 246,750 65,119 05/02/23
Hancock Richard B Director Director May 01 Sell 17.92 5,000 89,600 39,134 05/02/23
Hancock Richard B Director Director May 01 Option 4.67 5,000 23,350 44,134 05/02/23
Green Nicholas Stewart President & CEO President & CEO Apr 13 Sell 20.9165 7,000 146,416 83,531 04/14/23
SARGEN GREGORY Director Director Apr 11 Sell 20.2423 7,011 141,919 04/12/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Apr 09 Sell 19.8 736 14,573 40,119 04/11/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Apr 09 Sell 19.8 1,280 25,344 48,549 04/11/23
Green Nicholas Stewart President & CEO President & CEO Apr 09 Sell 19.8 7,598 150,440 90,531 04/11/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Apr 05 Sell 19 1,250 23,750 46,207 04/07/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Apr 05 Option 5.66 500 2,830 46,707 04/07/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Mar 14 Sell 19 5,000 95,000 46,957 03/16/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Mar 14 Option 5.66 2,000 11,320 48,957 03/16/23
Hancock Richard B Director Director Mar 01 Sell 16.59 5,000 82,950 39,134 03/03/23
Hancock Richard B Director Director Mar 01 Option 4.67 5,000 23,350 44,134 03/03/23
Hancock Richard B Director Director Feb 01 Sell 16.02 5,000 80,100 39,134 02/03/23
Hancock Richard B Director Director Feb 01 Option 4.67 5,000 23,350 44,134 02/03/23
Alegria Esther M. Director Director Jan 13 Sell 16.3233 5,321 86,856 01/17/23
Hancock Richard B Director Director Jan 12 Sell 16 5,000 80,000 39,134 01/13/23